Unbiased AI-powered news
1 stories related to this topic, newest first.
Substrate placeholder — needs reviewMerck announced last month its acquisition of Terns Pharmaceuticals for $6.7 billion. The deal follows promising early data from Terns' experimental leukemia drug. New details have emerged on the pricing negotiations.